These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 1686971)

  • 1. A novel membrane-bound serine esterase in human T4(+)-lymphocytes is a binding protein of envelope glycoprotein gp120 of HIV-1.
    Kido H; Fukutomi A; Katunuma N
    Biomed Biochim Acta; 1991; 50(4-6):781-9. PubMed ID: 1686971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel membrane-bound serine esterase in human T4+ lymphocytes immunologically reactive with antibody inhibiting syncytia induced by HIV-1. Purification and characterization.
    Kido H; Fukutomi A; Katunuma N
    J Biol Chem; 1990 Dec; 265(35):21979-85. PubMed ID: 1979328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of tryptase TL2 from human T4+ lymphocytes and inhibition of HIV-1 replication in H9 cells by recombinant aprotinin and bikunin homologues.
    Brinkmann T; Schäfers J; Gürtler L; Kido H; Niwa Y; Katunuma N; Tschesche H
    J Protein Chem; 1997 Aug; 16(6):651-60. PubMed ID: 9263127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tryptase TL2 in the membrane of human T4+ lymphocytes is a novel binding protein of the V3 domain of HIV-1 envelope glycoprotein gp 120.
    Kido H; Fukutomi A; Katunuma N
    FEBS Lett; 1991 Jul; 286(1-2):233-6. PubMed ID: 1677898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell membrane-associated serine protease, tryptase TL2, binds human immunodeficiency virus type 1 gp120 and cleaves the third-variable-domain loop of gp120. Neutralizing antibodies of human immunodeficiency virus type 1 inhibit cleavage of gp120.
    Niwa Y; Yano M; Futaki S; Okumura Y; Kido H
    Eur J Biochem; 1996 Apr; 237(1):64-70. PubMed ID: 8620895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular proteases involved in the pathogenicity of enveloped animal viruses, human immunodeficiency virus, influenza virus A and Sendai virus.
    Kido H; Niwa Y; Beppu Y; Towatari T
    Adv Enzyme Regul; 1996; 36():325-47. PubMed ID: 8869754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPC3, a V3 loop-derived synthetic peptide inhibitor of HIV-1 infection, binds to cell surface glycosphingolipids.
    Delézay O; Hammache D; Fantini J; Yahi N
    Biochemistry; 1996 Dec; 35(49):15663-71. PubMed ID: 8961929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural requirements for and consequences of an antiviral porphyrin binding to the V3 loop of the human immunodeficiency virus (HIV-1) envelope glycoprotein gp120.
    Neurath AR; Strick N; Debnath AK
    J Mol Recognit; 1995; 8(6):345-57. PubMed ID: 9052975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
    Peet NM; McKeating JA; de Souza JB; Roitt IM; Delves PJ; Lund T
    Virology; 1998 Nov; 251(1):59-70. PubMed ID: 9813203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and immunological reactivity of the principal neutralizing determinant V3 of glycoprotein gp120 of HIV-1.
    Borbe HC; Stuber G; Wagner R; Wolf H; Modrow S
    J Pept Sci; 1995; 1(2):109-23. PubMed ID: 9222988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of a single amino acid substitution within the V3 loop of HIV-1 gp120 on HLA-DR1-restricted CD4 T-cell recognition.
    Fernandez MH; Faith A; Higgins JA; Weber J; Rees AD
    Immunology; 1995 Jun; 85(2):176-83. PubMed ID: 7642208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Minimal sequence requirements for synthetic peptides derived from the V3 loop of the human immunodeficiency virus type 1 (HIV-1) to enhance HIV-1 binding to cells and infection.
    Zanotto C; Calderazzo F; Dettin M; Di Bello C; Autiero M; Guardiola J; Chieco-Bianchi L; De Rossi A
    Virology; 1995 Feb; 206(2):807-16. PubMed ID: 7856094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of human immunodeficiency virus infection by the lectin jacalin and by a derived peptide showing a sequence similarity with gp120.
    Favero J; Corbeau P; Nicolas M; Benkirane M; Travé G; Dixon JF; Aucouturier P; Rasheed S; Parker JW; Liautard JP
    Eur J Immunol; 1993 Jan; 23(1):179-85. PubMed ID: 8419169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-function relationships of the HIV-1 envelope V3 loop tropism determinant: evidence for two distinct conformations.
    Ebenbichler C; Westervelt P; Carrillo A; Henkel T; Johnson D; Ratner L
    AIDS; 1993 May; 7(5):639-46. PubMed ID: 7686374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human CD4+ T cells can discriminate the molecular and structural context of T epitopes of HIV gp120 and HIV p66.
    Manca F; Fenoglio D; Valle MT; Li Pira G; Kunkl A; Ferraris A; Saverino D; Lancia F; Mortara L; Lozzi L
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):227-37. PubMed ID: 7540488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human immunodeficiency virus gp120 and derived peptides activate protein tyrosine kinase p56lck in human CD4 T lymphocytes.
    Hivroz C; Mazerolles F; Soula M; Fagard R; Graton S; Meloche S; Sekaly RP; Fischer A
    Eur J Immunol; 1993 Mar; 23(3):600-7. PubMed ID: 7680610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between a membrane-associated serine proteinase of U-937 monocytes and peptides from the V3 loop of the human immunodeficiency virus type 1 (HIV-1) gp120 envelope glycoprotein.
    Avril LE; Di Martino-Ferrer M; Barin F; Gauthier F
    FEBS Lett; 1993 Feb; 317(1-2):167-72. PubMed ID: 8428626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Separation and partial characterization of proteinases with substrate specificity for basic amino acids from human MOLT-4 T lymphocytes: identification of those inhibited by variable-loop-V3 peptides of HIV-1 (human immunodeficiency virus-1) envelope glycoprotein.
    Harvima IT; Harvima RJ; Nilsson G; Ivanoff L; Schwartz LB
    Biochem J; 1993 Jun; 292 ( Pt 3)(Pt 3):711-8. PubMed ID: 8318003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of V3 loop-binding protein(s) of Molt-4 and U937 cells.
    Xu Y; Murakami T; Kawase S; Uchiyama T; Hattori T
    AIDS Res Hum Retroviruses; 1995 May; 11(5):563-70. PubMed ID: 7576912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of U-937 membrane-associated cathepsin G by GP120 (IIIB) and V3 loop-derived peptides from several strains of HIV-1.
    Avril LE; di Martino-Ferrer M; Brillard-Bourdet M; Gauthier F
    FEBS Lett; 1995 Jul; 367(3):251-6. PubMed ID: 7607317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.